Group of young business people sitting in an office together with colleagues. business meeting. Group of young business people sitting in an office together with colleagues. business meeting.

Upcoming P&T Session

Syndicated P&T Session: Atopic Dermatitis

On November 6th, observe a syndicated, simulated P&T session focused on the approvals of ruxolitinib cream (Opzelura), lebrikizumab, and tralokinumab for atopic dermatitis.

Learn how you can use P&T Perspectives to:

  • Gain an understanding of the impact of these agents in atopic dermatitis and how that might impact your brand.
  • Boost your brand by identifying the key differentiators and any unforeseen access barriers.

Interested in learning more about how you can take advantage of P&T Perspectives syndicated sessions?



Witness the Actual Discussions: